IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy

Xudong Fu,1 Xinjun Wang,1 Shaolong Zhou,1 Yanyan Zhang2 1The Fifth Affiliated Hospital of Zhengzhou University, 2School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People’s Republic of China Abstract: Despite advances in controlled drug delivery, drug delivery systems (DD...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fu X, Wang X, Zhou S, Zhang Y
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
MRI
Acceso en línea:https://doaj.org/article/17b09f0385f8485fa603c3e4ef8a76fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:17b09f0385f8485fa603c3e4ef8a76fc
record_format dspace
spelling oai:doaj.org-article:17b09f0385f8485fa603c3e4ef8a76fc2021-12-02T02:31:36ZIONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy1178-2013https://doaj.org/article/17b09f0385f8485fa603c3e4ef8a76fc2017-05-01T00:00:00Zhttps://www.dovepress.com/ionp-doped-nanoparticles-for-highly-effective-nir-controlled-drug-rele-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xudong Fu,1 Xinjun Wang,1 Shaolong Zhou,1 Yanyan Zhang2 1The Fifth Affiliated Hospital of Zhengzhou University, 2School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People’s Republic of China Abstract: Despite advances in controlled drug delivery, drug delivery systems (DDSs) with controlled activated drug release and high spatial and temporal resolution are still required. Theranostic nanomedicine is capable of diagnosis, therapy, and monitoring the delivery and distribution of drug molecules and has received growing interest. In this study, a near-infrared light-controlled “off–on” DDS with magnetic resonance imaging and magnetic targeting properties was developed using a hybrid nanoplatform (carbon nanotubes [CNTs]-iron oxide nanoparticle). Doxorubicin (DOX) and distearoyl-sn-glycero-3-phosphoethanolamine-PEG were adsorbed onto CNTs-iron oxide nanoparticle, and then to avoid the unexpected drug release during circulation, 1-myristyl alcohol was used to encapsulate the CNTs–drug complex. Herein, multifunctional DOX-loaded nanoparticles (NPs) with “off–on” state were developed. DOX-NPs showed an obvious “off–on” effect (temperature increase, drug release) controlled by near-infrared light in vitro and in vivo. In the in vivo and in vitro studies, DOX-NPs exhibited excellent magnetic resonance imaging ability, magnetic targeting property, high biosafety, and high antitumor combined therapeutic efficacy (hyperthermia combined with chemotherapy). These results highlight the great potential of DOX-NPs in the treatment of cancer. Keywords: controlled drug release, magnetic targeting, MRI, combination therapyFu XWang XZhou SZhang YDove Medical PressarticleControlled drug releasemagnetic targetingMRIcombination therapyMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 3751-3766 (2017)
institution DOAJ
collection DOAJ
language EN
topic Controlled drug release
magnetic targeting
MRI
combination therapy
Medicine (General)
R5-920
spellingShingle Controlled drug release
magnetic targeting
MRI
combination therapy
Medicine (General)
R5-920
Fu X
Wang X
Zhou S
Zhang Y
IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
description Xudong Fu,1 Xinjun Wang,1 Shaolong Zhou,1 Yanyan Zhang2 1The Fifth Affiliated Hospital of Zhengzhou University, 2School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, People’s Republic of China Abstract: Despite advances in controlled drug delivery, drug delivery systems (DDSs) with controlled activated drug release and high spatial and temporal resolution are still required. Theranostic nanomedicine is capable of diagnosis, therapy, and monitoring the delivery and distribution of drug molecules and has received growing interest. In this study, a near-infrared light-controlled “off–on” DDS with magnetic resonance imaging and magnetic targeting properties was developed using a hybrid nanoplatform (carbon nanotubes [CNTs]-iron oxide nanoparticle). Doxorubicin (DOX) and distearoyl-sn-glycero-3-phosphoethanolamine-PEG were adsorbed onto CNTs-iron oxide nanoparticle, and then to avoid the unexpected drug release during circulation, 1-myristyl alcohol was used to encapsulate the CNTs–drug complex. Herein, multifunctional DOX-loaded nanoparticles (NPs) with “off–on” state were developed. DOX-NPs showed an obvious “off–on” effect (temperature increase, drug release) controlled by near-infrared light in vitro and in vivo. In the in vivo and in vitro studies, DOX-NPs exhibited excellent magnetic resonance imaging ability, magnetic targeting property, high biosafety, and high antitumor combined therapeutic efficacy (hyperthermia combined with chemotherapy). These results highlight the great potential of DOX-NPs in the treatment of cancer. Keywords: controlled drug release, magnetic targeting, MRI, combination therapy
format article
author Fu X
Wang X
Zhou S
Zhang Y
author_facet Fu X
Wang X
Zhou S
Zhang Y
author_sort Fu X
title IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
title_short IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
title_full IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
title_fullStr IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
title_full_unstemmed IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy
title_sort ionp-doped nanoparticles for highly effective nir-controlled drug release and combination tumor therapy
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/17b09f0385f8485fa603c3e4ef8a76fc
work_keys_str_mv AT fux ionpdopednanoparticlesforhighlyeffectivenircontrolleddrugreleaseandcombinationtumortherapy
AT wangx ionpdopednanoparticlesforhighlyeffectivenircontrolleddrugreleaseandcombinationtumortherapy
AT zhous ionpdopednanoparticlesforhighlyeffectivenircontrolleddrugreleaseandcombinationtumortherapy
AT zhangy ionpdopednanoparticlesforhighlyeffectivenircontrolleddrugreleaseandcombinationtumortherapy
_version_ 1718402393332252672